Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.55563/clinexprheumatol/7afn90 http://scihub22266oqcxt.onion/10.55563/clinexprheumatol/7afn90 33555252!ä!33555252 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Rheumatol 2021 ; 39 (1): 196-202 Nephropedia Template TP {{tp|p=33555252|t=2021. Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives |pdf=|usr=}}{{33555252}} gab.com Text Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives JO: Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33555252 #FOAvip Since January 2020, the whole world has been facing the worst epidemic for a century. SARS-CoV- 2 infection has so far caused more than one million deaths, with the only measures capable of containing the spread of the virus being social distancing, frequent hand washing, and the wearing of masks. Vaccine development was urgently needed and there are now more than 90 candidate vaccines being developed using different technologies. The European Medicines Agency has recently approved a second mRNA-based vaccine, but the introduction of vaccines has raised some doubts about patients with rheumatic disease, who are at high risk of infection because of disease activity and the therapies used to treat it. The aim of this study was to investigate how vaccines may interact with the immune system and treatment of such patients, and how to monitor the post-vaccine antibody titres and T cell responses in order to assess their efficacy and safety. Twit Text FOAVip Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives ????Clin Exp Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33555252 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33555252 #FOAvip English Wikipedia <ref>{{Cite pmid|33555252}}</ref> Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives #MMPMID33555252 Benucci M; Infantino M; Marotto D; Ardizzone S; Manfredi M; Sarzi-Puttini P Clin Exp Rheumatol 2021[Jan]; 39 (1): 196-202 PMID33555252show ga Since January 2020, the whole world has been facing the worst epidemic for a century. SARS-CoV- 2 infection has so far caused more than one million deaths, with the only measures capable of containing the spread of the virus being social distancing, frequent hand washing, and the wearing of masks. Vaccine development was urgently needed and there are now more than 90 candidate vaccines being developed using different technologies. The European Medicines Agency has recently approved a second mRNA-based vaccine, but the introduction of vaccines has raised some doubts about patients with rheumatic disease, who are at high risk of infection because of disease activity and the therapies used to treat it. The aim of this study was to investigate how vaccines may interact with the immune system and treatment of such patients, and how to monitor the post-vaccine antibody titres and T cell responses in order to assess their efficacy and safety. |*COVID-19[MESH] |*Rheumatic Diseases[MESH] |*Vaccines/adverse effects[MESH] |Humans[MESH] |SARS-CoV-2[MESH]Vaccination against SARS-CoV-2 in patients with rheumatic diseases: do(epmc).pdf DeepDyve Pubget Overpricing